Proviron HILMA Biocare
Proviron (Mesterolone)

Trade Name: Proviron
Chemical Name: Mesterolone
Route of Administration: Oral
Half-life: Approximately 12 hours 

Overview

Proviron was developed by Schering in 1934, making it one of the earliest drugs used in hormone replacement therapy. Mesterolone, the active compound, closely resembles dihydrotestosterone (DHT), being a potent androgen with very weak anabolic effects. Due to its profile, Proviron is not typically used on its own for muscle gain but plays a significant role in steroid cycles.

Mechanism of Action

Proviron exerts its primary effects by binding strongly to 60-65% of the Sex Hormone Binding Globulin (SHBG). This binding displaces other weaker steroids from SHBG, increasing the free, active forms of hormones such as testosterone and other steroids in the bloodstream. Since approximately 95-99% of circulating testosterone is bound to SHBG, Proviron’s high affinity helps elevate the free testosterone levels, thereby enhancing androgen activity.

Additionally, Proviron can bind to aromatase enzymes, inhibiting the conversion of androgens into estrogen. This anti-estrogenic property makes it a valuable addition during cycles to control estrogen-related side effects, especially in pre-contest phases.

Benefits

Acts as a moderate anti-estrogen by inhibiting aromatase activity

Increases levels of free, active androgens by displacing them from SHBG

Enhances muscle hardness and density

No estrogenic side effects due to its anti-estrogenic properties

Not c-17 alpha alkylated, reducing liver toxicity risk

Safety and Usage

Proviron is not c-17 alpha alkylated, meaning it is less hepatotoxic compared to many oral steroids. Its modification with a methyl group at carbon one protects it from extensive liver metabolism, similar to oral Primobolan, making it one of the safest oral steroids available.

Dosage Recommendations: 

Typical doses range from 20 mg to 100 mg per day. 

Some users may take 150-200 mg per day, but doses beyond 100 mg often yield diminishing returns. 

Many find 50-100 mg daily to be the most effective and safe dosage.

Cycle Use: 

Usually used during cutting or pre-contest cycles for 4-8 weeks. 

Can be combined with other steroids to improve results without significantly increasing androgenic side effects.

Side Effects: 

Androgenic effects such as oily skin, acne, facial/body hair growth, and male pattern baldness in predisposed individuals. 

Females should avoid Proviron due to the risk of virilization. 

Testosterone suppression is minimal, allowing for easier post-cycle therapy (PCT).

Conclusion

Proviron (Mesterolone) is a versatile and relatively safe oral androgen that effectively increases free testosterone and exerts anti-estrogenic effects. Its lack of liver toxicity and ability to enhance the activity of other steroids make it a valuable addition to many cycles, suitable even for beginners seeking to improve their results without significant risk.